Recognizing Exemplary Efforts

It is nice to be recognized but I didn’t realize it would be as rewarding to congratulate someone or to write someone a letter of appreciation/recognition!

As the chair of Diagnostic Imaging-Cardiorespiratory Services at work, I have the pleasure of recognizing members for their contributions.

Have you recently taken a step back and looked at your team? Take the time to know your team, and thank those who have made a great contribution.

Please follow and like us:

Dr. Google

As healthcare professionals we have a duty to guide patients in making better decisions based on more current, accurate and proven knowledge.
First we need to be up to date with the latest guidelines and knowledge in our field.
Second, we need to create an open and comfortable space for your patients so they can be open about their thoughts and their choices.
Third, be aware of the latest trends and claims so you can educate your patients on false claims.

Please follow and like us:

Networking

Tired but still showed up.
Didn’t know many people but still made the effort.
Growth and networking is not easy. Requires genuine attempt to listen to others.
But is exciting and rewarding.
Except no outcome but to learn and you get the most out of the interactions.
Make an effort. Meet people in other fields.

Please follow and like us:

ASBESTOS

Canadian government is taking steps to limit the use of Asbestos. While this is not a complete ban, and some exceptions exists, it is still a step toward the right direction.

Occasionally at the PFT lab we have individuals who have been exposed to Asbestos, and we perform the testing to rule out interstitial lung disease.

CBC has a piece on this which you can check out at:https://www.cbc.ca/news/politics/trudeau-asbestos-cancer-regulations-1.4867684

Please follow and like us:

RA

At the Pulmonary Function Testing lab we assess and monitor patients who have Rheumatoid Arthritis (RA).
“Interstitial lung disease may be a manifestation of RA or may be a complication of RA therapies, such as methotrexate and leflunomide.” -Daniel Aletaha, MD and Josef S. Smolen, MD.
If you want to learn more about RA, check out:
Diagnosis and Management of Rheumatoid Arthritis-A Review. Oct 2 2018
https://jamanetwork.com/journals/jama/fullarticle/2705192?guestAccessKey=4054e5dc-45b4-4fd7-bec5-e6a9a4c14a87
Please follow and like us: